Connection

Contact Us
If you have any questions or feedback please contact us.

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Bowles, Daniel

One or more keywords matched the following items that are connected to Bowles, Daniel

Item Type	Name
Academic Article	Vismodegib in basal cell carcinoma.
Academic Article	Multi-targeted tyrosine kinase inhibitors in clinical development: focus on XL-184 (cabozantinib).
Academic Article	Crizotinib for the treatment of patients with advanced non-small cell lung cancer.
Concept	Pyridines
Academic Article	Phase I dose-escalation trial of the oral investigational Hedgehog signaling pathway inhibitor TAK-441 in patients with advanced solid tumors.
Academic Article	Cabozantinib use in renal cell carcinoma.
Academic Article	Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study.
Academic Article	Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial.
Academic Article	Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial.
Academic Article	Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial.
Academic Article	Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study.

Search Criteria